Cubist Systematic Strategies, LLC Coherus Bio Sciences, Inc. Transaction History

Cubist Systematic Strategies, LLC

$17.3 Billion
Q1 2024

A detailed history of Cubist Systematic Strategies, LLC transactions in Coherus Bio Sciences, Inc. stock. As of the latest transaction made, Cubist Systematic Strategies, LLC holds 80,063 shares of CHRS stock, worth $138,508. This represents 0.0% of its overall portfolio holdings.

Number of Shares

80,063

Previous 387,240 79.32%

Holding current value

$138,508

Previous $1.29 Million 85.18%

% of portfolio

0.0%

Previous 0.01%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$2.02 - $3.14 $620,497 - $964,535	-307,177 Reduced 79.32%	80,063 $191,000
Q4 2023 Feb 14, 2024	SELL	$1.59 - $3.85 $308,033 - $745,868	-193,732 Reduced 33.35%	387,240 $1.29 Million
Q3 2023 Nov 14, 2023	BUY	$3.74 - $5.45 $2.1 Million - $3.06 Million	560,998 Added 2808.64%	580,972 $2.17 Million
Q2 2023 Aug 14, 2023	SELL	$3.79 - $8.3 $528,477 - $1.16 Million	-139,440 Reduced 87.47%	19,974 $85,000
Q1 2023 May 15, 2023	SELL	$5.89 - $10.52 $256,144 - $457,493	-43,488 Reduced 21.43%	159,414 $1.09 Million

Q4 2022 Feb 14, 2023	SELL	$5.69 - $10.07 $121,788 - $215,538	-21,404 Reduced 9.54%	202,902 $1.61 Million
Q3 2022 Nov 14, 2022	BUY	$7.17 - $13.87 $1.41 Million - $2.73 Million	196,496 Added 706.57%	224,306 $2.16 Million
Q2 2022 Aug 15, 2022	BUY	$5.86 - $13.23 $52,950 - $119,546	9,036 Added 48.13%	27,810 $201,000
Q1 2022 May 16, 2022	SELL	$10.92 - $16.41 $1.3 Million - $1.96 Million	-119,358 Reduced 86.41%	18,774 $242,000
Q4 2021 Feb 14, 2022	BUY	$15.81 - $18.99 $1.87 Million - $2.25 Million	118,416 Added 600.61%	138,132 $2.21 Million
Q3 2021 Nov 15, 2021	SELL	$12.68 - $17.79 $268,613 - $376,863	-21,184 Reduced 51.79%	19,716 $317,000
Q2 2021 Aug 16, 2021	SELL	$12.95 - $15.41 $394,534 - $469,481	-30,466 Reduced 42.69%	40,900 $566,000
Q1 2021 May 17, 2021	BUY	$14.42 - $21.39 $871,919 - $1.29 Million	60,466 Added 554.73%	71,366 $1.04 Million
Q4 2020 Feb 16, 2021	SELL	$16.56 - $18.94 $35,074 - $40,114	-2,118 Reduced 16.27%	10,900 $189,000
Q3 2020 Nov 16, 2020	BUY	$17.41 - $19.89 $226,643 - $258,928	13,018 New	13,018 $239,000
Q2 2020 Aug 14, 2020	SELL	$14.43 - $19.16 $1.63 Million - $2.16 Million	-112,634 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$11.67 - $22.53 $784,142 - $1.51 Million	67,193 Added 147.87%	112,634 $1.83 Million
Q4 2019 Feb 14, 2020	BUY	$16.33 - $21.37 $287,456 - $376,176	17,603 Added 63.23%	45,441 $818,000
Q3 2019 Nov 14, 2019	BUY	$16.3 - $23.37 $391 - $560	24 Added 0.09%	27,838 $564,000
Q2 2019 Aug 14, 2019	BUY	$13.1 - $22.1 $165,990 - $280,029	12,671 Added 83.68%	27,814 $615,000
Q1 2019 May 15, 2019	SELL	$8.38 - $15.5 $3,737 - $6,913	-446 Reduced 2.86%	15,143 $207,000
Q4 2018 Feb 14, 2019	SELL	$8.65 - $16.28 $149,549 - $281,464	-17,289 Reduced 52.59%	15,589 $141,000
Q3 2018 Nov 14, 2018	BUY	$14.45 - $20.25 $133,445 - $187,008	9,235 Added 39.06%	32,878 $542,000
Q2 2018 Aug 14, 2018	BUY	$10.25 - $17.45 $242,340 - $412,570	23,643 New	23,643 $331,000
Q1 2018 May 15, 2018	SELL	$9.1 - $13.7 $100,400 - $151,152	-11,033 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$8.35 - $14.4 $92,125 - $158,875	11,033	11,033 $97,000

Others Institutions Holding CHRS

# of Institutions

148

Shares Held

82.9M

Call Options Held

184K

Put Options Held

255K

View Full List

About Coherus BioSciences, Inc.

Ticker CHRS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,724,600
Market Cap $134M
Description
Coherus BioSciences, Inc., a biopharmaceutical company, focuses on the biosimilar and immuno-oncology market primarily in the United States. The company markets UDENYCA, a biosimilar to Neulasta, a long-acting granulocyte stimulating colony factor in the United States. Its pipeline products include biosimilars of Humira, Avastin, and Lucentis. T...

More about CHRS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.

Account

Cubist Systematic Strategies, LLC Coherus Bio Sciences, Inc. Transaction History